8-methoxycaffeine-induced protein-associated DNA breaks in isolated L1210 cell nuclei
- PMID: 2175203
8-methoxycaffeine-induced protein-associated DNA breaks in isolated L1210 cell nuclei
Abstract
8-methoxycaffeine (8-MOC) is a caffeine derivative more potent than its parental compound in inducing chromosomal aberrations. 8-MOC has been postulated to produce chromosomal aberrations by DNA topoisomerase II inhibition. The effect of 8-MOC on nuclear DNA were studied by alkaline elution experiments and compared with those of Ellipticine and Adriamycin (ADR). Like Ellipticine and ADR, 8-MOC induced single strand breaks (SSBs), double strand breaks (DSBs), and DNA-protein cross-links (DPCs) in a bell-shaped manner with respect to drug concentration. As in the case of ADR and Ellipticine, 8-MOC induced equal SSB and DPC frequencies. These results could suggest that 8-MOC induces DNA breaks by interacting with DNA topoisomerase II or with a similar DNA metabolism enzyme.
Similar articles
-
Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.Cancer Res. 1988 Mar 15;48(6):1404-9. Cancer Res. 1988. PMID: 2830964
-
Production of protein-associated DNA breaks by 8-methoxycaffeine, caffeine and 8-chlorocaffeine in isolated nuclei from L1210 cells: comparison with those produced by topoisomerase II inhibitors.Carcinogenesis. 1991 Oct;12(10):1781-90. doi: 10.1093/carcin/12.10.1781. Carcinogenesis. 1991. PMID: 1657426
-
Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.Mol Pharmacol. 1993 Oct;44(4):767-74. Mol Pharmacol. 1993. PMID: 8232227
-
Development of drug derivatives without cross-resistance to parent compounds.Cancer Treat Rev. 1990 Dec;17 Suppl A:67-79. doi: 10.1016/0305-7372(90)90018-b. Cancer Treat Rev. 1990. PMID: 1965493 Review. No abstract available.
-
Molecular and biochemical pharmacology of mitoxantrone.Cancer Treat Rev. 1983 Dec;10 Suppl B:3-11. doi: 10.1016/0305-7372(83)90016-6. Cancer Treat Rev. 1983. PMID: 6362876 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials